Ph.D., Vice President, Corporate and Business Development, Inivata, LTD.
John Beeler, Ph.D. is Vice President of Corporate and Business Development of Inivata, a clinical cancer genomics company focused on developing clinical applications for circulating tumor DNA (ctDNA). John has over twenty years of product and business development experience spanning the pharmaceutical and diagnostics industries focused on forging companion diagnostic co-development partnerships together with establishing strategic partnerships and driving broader strategies in the oncology market place for personalized medicine applications. John has previously served in a business development capacity for bioMerieux, S.A., a leading global in vitro diagnostic company and OncoMethylome Sciences (MDx Health), a personalized medicine company in addition to having held various commercial and product development positions at GlaxoSmithKline. John received a PhD in Pharmacology from the University of South Carolina and completed his post-doctoral training in the Laboratory of Cellular and Molecular Biology at the National Cancer Institute.
Presentation Title and Company Description
Liquid Biopsy Showcase: How Liquid Biopsy Can Transform Early Stage NSCLC
Inivata is a global clinical cancer genomics company utilizing a proprietary, industry-leading liquid biopsy platform to transform patient care. Inivata has established collaborations with world-leading cancer centers and academic institutions, and is partnering with pharmaceutical and biotechnology companies. The Company has a CLIA lab in Research Triangle Park, NC and laboratories in Cambridge, UK.